Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001062993-15-000404
Filing Date
2015-01-30
Accepted
2015-01-30 08:32:21
Documents
6
Period of Report
2015-01-29

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A schedpre14a.htm PRE 14A 152477
2 EXHIBIT A exhibita.htm EX-99.1 539
3 EXHIBIT 99.2 exhibitb.htm EX-99.2 1935
4 GRAPHIC exhibitax1x1.jpg GRAPHIC 104738
5 GRAPHIC exhibitbx1x1.jpg GRAPHIC 91839
6 GRAPHIC anavexlogo.jpg GRAPHIC 4139
  Complete submission text file 0001062993-15-000404.txt   433082
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 000-51652 | Film No.: 15560834
SIC: 8731 Services-Commercial Physical & Biological Research